Jpmorgan Chase & CO Pulmonx Corp Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Pulmonx Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,030,520 shares of LUNG stock, worth $7.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,030,520

Previous 264,575 289.5%

Holding current value

$7.34 Million

Previous $2.45 Million 166.44%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$5.77 - $9.82 $4.42 Million - $7.52 Million	765,945 Added 289.5%	1,030,520 $6.53 Million
Q1 2024 May 10, 2024	BUY	$8.71 - $14.65 $1.85 Million - $3.11 Million	212,312 Added 406.24%	264,575 $2.45 Million
Q4 2023 Feb 12, 2024	BUY	$7.89 - $13.14 $211,696 - $352,559	26,831 Added 105.5%	52,263 $666,000
Q3 2023 Nov 14, 2023	SELL	$9.88 - $14.0 $39,401 - $55,832	-3,988 Reduced 13.56%	25,432 $262,000
Q2 2023 Aug 11, 2023	SELL	$10.78 - $13.65 $1.28 Million - $1.62 Million	-118,798 Reduced 80.15%	29,420 $385,000
Q1 2023 May 18, 2023	BUY	$7.49 - $12.54 $333,462 - $558,293	44,521 Added 42.93%	148,218 $1.66 Million
Q1 2023 May 11, 2023	BUY	$7.49 - $12.54 $343,663 - $575,372	45,883 Added 79.36%	103,697 $1.16 Million
Q4 2022 Feb 13, 2023	BUY	$4.92 - $17.35 $123,250 - $434,634	25,051 Added 76.46%	57,814 $487,000
Q3 2022 Nov 14, 2022	BUY	$15.35 - $23.99 $15,749 - $24,613	1,026 Added 3.23%	32,763 $545,000
Q2 2022 Aug 11, 2022	BUY	$14.0 - $27.95 $68,978 - $137,709	4,927 Added 18.38%	31,737 $467,000
Q1 2022 May 11, 2022	SELL	$21.13 - $35.65 $523,897 - $883,906	-24,794 Reduced 48.05%	26,810 $665,000
Q4 2021 Feb 10, 2022	SELL	$29.72 - $45.1 $3.2 Million - $4.85 Million	-107,589 Reduced 67.58%	51,604 $1.66 Million
Q3 2021 Nov 12, 2021	BUY	$35.98 - $44.48 $5.73 Million - $7.08 Million	159,193 New	159,193 $5.73 Million

Others Institutions Holding LUNG

# of Institutions

118

Shares Held

30.6M

Call Options Held

400

Put Options Held

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $265M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Pulmonx Corp Transaction History